Markus Mandler
12Patents
2h-index
14Co-inventors
47Inventor score
Filing activity: Feb 23, 2009 → Jul 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8613931B2 | Compounds for treating beta-amyloidoses | Chemistry; Metallurgy | 5 | Active |
| US9724399B2 | Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders | Physics | 3 | Active |
| US11065273B2 | Treatment and prevention of alzheimer's disease (AD) | Human Necessities | 1 | Active |
| US10646565B2 | Treatment of alzheimer'S disease (AD) with an aluminum salt | Human Necessities | 1 | Active |
| US10517935B2 | Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders | Physics | 1 | Active |
| US11147873B2 | Treatment of Alzheimer's Disease (AD) with an aluminum salt | Human Necessities | 1 | Active |
| US11857568B2 | Treatment and prevention of Alzheimer's disease (AD) | Human Necessities | 0 | Active |
| US11534484B2 | Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy | Physics | 0 | Active |
| US8409581B2 | Compounds for treating amyloidoses | Chemistry; Metallurgy | 0 | Active |
| US10478454B2 | Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide | Human Necessities | 0 | Active |
| US9964547B2 | Method for detecting aSyn-specific antibodies in a biological sample | Physics | 0 | Active |
| US8828942B2 | Means for treating synucleinopathies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.